Max Sung, MD

Max Sung, MD, is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. He has been on the faculty at Mount Sinai since 1987. Dr. Sung specializes in gastrointestinal cancers including liver, bile duct, pancreas, esophagus, stomach, colon/rectum, and anus cancers. His approach to cancer treatment is multi-disciplinary, and involves collaboration with other specialties such as surgery, interventional radiology, and radiation therapy. Dr. Sung has held numerous leadership roles at Mount Sinai, including Medical Director of The Ruttenberg Treatment Center and Chair of the Data and Safety Monitoring Committee for cancer clinical trials. Dr. Sung is involved in clinical cancer research and has authored numerous peer-reviewed publications on innovative and translational treatments. Dr. Sung is fluent in English and Chinese (Cantonese and Mandarin), and has a working knowledge of German and French.

Languages Spoken: English